Breast Cancer Clinical Trials
Find clinical trials for breast cancer. Search for breast cancer clinical trials in different cities and states across the United States.
Aromatase InhibitorAromatase Inhibitor Clinical Trial
Sponsor:
National Institute of General Medical Sciences (NIGMS)
Location:
Code:
NCT00228956
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 40 - 70
Healthy Volunteers: Not accepted
Interventions
pharmacodynamic analysis
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefStereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
Sponsor:
Hamilton Health Sciences Corporation
Location:
Code:
NCT04177056
Conditions
Bone Metastases
Prostate Cancer
Breast Cancer
Renal Cell Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SBRT
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT03941756
Conditions
Anatomic Stage III Breast Cancer AJCC v8
Breast Inflammatory Carcinoma
Locally Advanced Breast Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Indocyanine Green
Lymphangiography
Lymphovenous Bypass
Mobile Health AppMobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Location:
Code:
NCT06361056
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Survey
mHealth app
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
Observational StudyA Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
Sponsor:
University of Chicago
Location:
Code:
NCT03729115
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 25+
Healthy Volunteers: Accepted
Interventions
Magnetic Resonance Imaging (MRI)
Nutrition InterventionFood for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Location:
Code:
NCT06582615
Conditions
Anatomic Stage II Breast Cancer AJCC V8
Anatomic Stage III Breast Cancer AJCC V8
Triple-Negative Breast Carcinoma
Eligibility Criteria
Sex: Female
Age: 40 - 65
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Cognitive Assessment
Dietary Intervention
Medical Device Usage and Evaluation
Questionnaire Administration
PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Sponsor:
Pfizer
Location:
Code:
NCT06760637
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07220060
letrozole
abemaciclib
palbociclib
ribociclib
Novel TherapyHarnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Location:
Code:
NCT03769415
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Intrinsic Subtyping of Primary Breast Cancer